Hearing Loss Trial, Recruiting (NCT06930170)

Hearing Loss Trial, Recruiting NCT06930170 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06930170 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child is between 4 and 6 years old at the time of joining the trial
The child mainly communicates using spoken French
The child has been diagnosed with hearing loss in one ear only, or significantly worse hearing in one ear than the other — either with no hearing loss in the better ear, or only mild hearing loss in the better ear (confirm specific hearing test results with trial site)
Both parents or legal guardians have given written agreement for the child to take part (or one guardian, if that person is solely responsible)
The child is covered by a health insurance system

Who may not be able to join:

The child has a serious neurological condition identified through a brain scan or specialist assessment
The child has a severe cognitive disability, serious developmental delay, or significant psychiatric condition
The child has a severe structural problem with the inner ear (cochlea) or the nerve connected to it
The family's personal or social situation would make it difficult to attend regular follow-up appointments over a long period
The family does not speak French well enough to communicate in spoken French
The child already uses a specific type of hearing device called a CROS or BiCROS system
The child has a medical reason why they cannot have implant surgery or general anaesthesia, including not being up to date with meningitis or pneumococcal vaccinations

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nathalie LOUNDON, MD, PHD, Unité d'Audiophonologie et d'Implantation cochléaire - Service d'ORL et chirurgie cervico-faciale Hôpital Necker.

Phone: 01 71 39 67 82

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06930170

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 01 71 39 67 82

More information: https://clinicaltrials.gov/study/NCT06930170

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child is between 4 and 6 years old at the time of joining the trial
The child mainly communicates using spoken French
The child has been diagnosed with hearing loss in one ear only, or significantly worse hearing in one ear than the other — either with no hearing loss in the better ear, or only mild hearing loss in the better ear (confirm specific hearing test results with trial site)
Both parents or legal guardians have given written agreement for the child to take part (or one guardian, if that person is solely responsible)
The child is covered by a health insurance system

Who may not be able to join:

The child has a serious neurological condition identified through a brain scan or specialist assessment
The child has a severe cognitive disability, serious developmental delay, or significant psychiatric condition
The child has a severe structural problem with the inner ear (cochlea) or the nerve connected to it
The family's personal or social situation would make it difficult to attend regular follow-up appointments over a long period
The family does not speak French well enough to communicate in spoken French
The child already uses a specific type of hearing device called a CROS or BiCROS system
The child has a medical reason why they cannot have implant surgery or general anaesthesia, including not being up to date with meningitis or pneumococcal vaccinations

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

9 March 2026

Est. completion

1 January 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

French simplified matrix test (FraSimat) SAABAN condition at Month 18

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov